Cabaletta Bio is trading 5.03% up in pre-market at $1.88, compared with the October 12 close of $1.79; no confirmed company-specific announcement explains the October 13 move.
- The latest located company release, dated October 5, discussed trial recruitment and inducement grants.
- The broad market backdrop is mixed and does not clearly explain the rise.